Management of chronic obstructive pulmonary disease

Comprehensive Therapy
Dipak Chandy, Wilbert S Aronow

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity throughout the world. It is the only cause of death among the top 10 causes that is increasing and is expected to become the third leading cause of death in the world by 2020. A diagnosis of COPD should be considered in any patient with previous exposure to risk factors for the disease and/or the presence of chronic cough, sputum production, or dyspnea. Patients with COPD are categorized into five stages based on their pulmonary function tests and symptoms. Smoking cessation is the single most effective way to halt the progression of COPD and prolong life. Pharmacological management of stable COPD includes the use of bronchodilators (beta2 agonists, anticholinergics and methylxanthines) and inhaled corticosteroids. Other adjunctive measures include vaccination, oxygen therapy, pulmonary rehabilitation, and certain surgical measures like bullectomy and lung transplantation. Management of acute exacerbations includes the use of systemic steroids, antibiotics, bronchodilators, and oxygen therapy. During very severe exacerbations, patients may need ventilatory support.

References

Feb 1, 1987·Annals of Internal Medicine·Nick R AnthonisenN A Nelson
Nov 20, 1986·The New England Journal of Medicine·M S SimberkoffD S Shepard
Jan 1, 1986·Annals of Internal Medicine·J H Williams, K M Moser
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·M DecramerP Rogiers
Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·W H ThompsonJ J Crowley
Jul 21, 2000·American Journal of Respiratory and Critical Care Medicine·Kathryn L RiceDennis E Niewoehner
Nov 18, 2000·Chest·G H GuyattR S Goldstein
Aug 25, 2001·American Journal of Respiratory and Critical Care Medicine·S HeindlS Andreas
Aug 16, 2002·The New England Journal of Medicine·Sanjay SethiTimothy F Murphy
Sep 3, 2002·American Journal of Respiratory and Critical Care Medicine·N R AnthonisenRobert P Murray
Feb 14, 2003·Lancet·P M A CalverleyTRial of Inhaled STeroids ANd long-acting beta2 agonists study group
Jul 29, 2003·The European Respiratory Journal·Leonardo M FabbriGOLD Scientific Committee
Nov 6, 2003·JAMA : the Journal of the American Medical Association·D D SinNick R Anthonisen
Dec 19, 2003·The European Respiratory Journal·P M A CalverleyH Olsson

Citations

Jul 13, 2013·Immunological Investigations·Li-Xin ZhangJun-xing Huang

Related Concepts

Antibiotics
Broncholytic Effect
Glucocorticoid Effect
Trivalent Live Attenuated Influenza Vaccine
Oxygen Therapy Care
Severity of Illness Index
Cessation of Smoking
Pneumovax
Chronic Airflow Obstruction

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.